HIVE Blockchain Announces Filing of Prospectus Supplement and Automatic Exercise of Special Warrants

HIVE Blockchain Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: HBF) (the "Company" or "HIVE") is pleased to announce that is has filed a prospectus supplement (the "Prospectus Supplement") dated January 7, 2022 to its amended and restated final short form base shelf prospectus dated January 4, 2022 with the securities regulatory authorities in in each Province of Canada, except Québec, in connection with its private placement of 19,170,500 special warrants (the "Special Warrants") completed on November 30, 2021 (the "Offering"). The Prospectus Supplement qualifies for distribution 19,170,500 units (the "Units") issuable upon the automatic exercise of the Special Warrants for no additional consideration. Stifel GMP acted as lead underwriter and sole bookrunner in connection with the Offering, with a syndicate including BMO Capital Markets, Canaccord Genuity Corp. and PI Financial Corp.

In accordance with the terms of a special warrant indenture dated November 30, 2021 between the Company and TSX Trust Company, as a result of filing the Prospectus Supplement and the satisfaction of the qualification deadline, effective on or around January 11, 2022, each Special Warrant will be automatically be exercised into one Unit comprised of one common share of the Company (a "Share") and one-half of one common share purchase warrant (each whole common share purchase warrant being a "Warrant"). Each Warrant is exercisable for one Share on or before May 30, 2024 at an exercise price of $6.00 per Share. For further information on the Special Warrants, please see the Company's news release dated November 30, 2021, a copy of which is available on SEDAR (www.sedar.com).

A copy of the Prospectus Supplement, including the documents incorporated by reference therein, is available under the Company's SEDAR profile at www.sedar.com.

The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.

By Newsfile Corp